Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - The page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor update to the page's underlying versioning. - There are no changes to the visible content or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-05-15T07:50:49.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page footer was updated to show a new ClinicalTrials.gov release revision number (from v3.5.2 to v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-24T06:15:37.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:42:59.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Results have been submitted for this study, replacing the previous 'No Results Posted' status.
    Difference
    0.0%
    Check dated 2026-03-26T11:28:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-19T04:59:08.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Site revision tag updated from v3.4.2 to v3.4.3. The change does not modify any study data or page content.
    Difference
    0.0%
    Check dated 2026-03-12T00:55:05.000Z thumbnail image

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.